Cultures of human embryonic stem cells:: serum replacement medium or serum-containing media and the effect of basic fibroblast growth factor

被引:70
作者
Koivisto, H
Hyvärinen, M
Strömberg, AM
Inzunza, J
Matilainen, E
Mikkola, M
Hovatta, O
Teerijoki, H
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Dept Clin Sci, S-14186 Huddinge, Sweden
[2] Univ Helsinki, Biomedicum, FIN-00014 Helsinki, Finland
基金
芬兰科学院; 英国医学研究理事会;
关键词
basic fibroblast growth factor; feeder cells; human embryonic stem cells; serum replacement;
D O I
10.1016/S1472-6483(10)62150-5
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Human embryonic stem (hES) cells have traditionally been cultured in medium containing fetal calf serum (FCS) and mouse fibroblasts as feeder cells. The use of animal derived materials carries a risk of transmitting animal pathogens, and they are not optimal in cultures aimed at cell transplantation in humans. This technical study aiming at facilitating IVF units to establish new hES cell lines, has systematically compared the non-differentiated growth of the hES cell line HS237, originally derived and thereafter cultured using human foreskin fibroblasts as feeder cells, by culturing it in media containing serum replacement (SR; 10, 15, 20%), FCS, and human serum. In addition, optimal concentrations of insulin-transferrin-selenium (ITS) mixture and the effect of basic fibroblast growth factor (bFGF) have also been studied. Cellular growth was monitored daily and maintenance of their non-differentiated character was studied using antibodies against TRA-1-60, TRA-1-81 and SSEA-4 and expression of Oct-4. The hES cells proliferated fastest when 20% of SR was used. In human serum-containing medium, the cells underwent extensive spontaneous differentiation within a few passages. The FCS supported the non-differentiated growth poorly. Basic fibroblast growth factor supported non-differentiated growth, the highest concentration (8 ng/ml) giving the best result, while ITS was not beneficial.
引用
收藏
页码:330 / 337
页数:8
相关论文
共 18 条
[1]   Human feeder layers for human embryonic stem cells [J].
Amit, M ;
Margulets, V ;
Segev, H ;
Shariki, K ;
Laevsky, I ;
Coleman, R ;
Itskovitz-Eldor, J .
BIOLOGY OF REPRODUCTION, 2003, 68 (06) :2150-2156
[2]   Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture [J].
Amit, M ;
Carpenter, MK ;
Inokuma, MS ;
Chiu, CP ;
Harris, CP ;
Waknitz, MA ;
Itskovitz-Eldor, J ;
Thomson, JA .
DEVELOPMENTAL BIOLOGY, 2000, 227 (02) :271-278
[3]   Feeder layer- and serum-free culture of human embryonic stem cells [J].
Amit, M ;
Shariki, C ;
Margulets, V ;
Itskovitz-Eldor, J .
BIOLOGY OF REPRODUCTION, 2004, 70 (03) :837-845
[4]   Characterization and differentiation of human embryonic stem cells [J].
Carpenter, MK ;
Rosler, E ;
Rao, MS .
CLONING AND STEM CELLS, 2003, 5 (01) :79-88
[5]  
EDWARDS RG, 2002, REPROD BIOMED ONLINE, V4, P236
[6]   HUMAN CHORIONIC-GONADOTROPIN SECRETED BY PREIMPLANTATION EMBRYOS CULTURED INVITRO [J].
FISHEL, SB ;
EDWARDS, RG ;
EVANS, CJ .
SCIENCE, 1984, 223 (4638) :816-818
[7]   Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens [J].
Henderson, JK ;
Draper, JS ;
Baillie, HS ;
Fishel, S ;
Thomson, JA ;
Moore, H ;
Andrews, PW .
STEM CELLS, 2002, 20 (04) :329-337
[8]  
HOVATTA O, 2003, HUMAN REPROD, V18, P1
[9]  
INZUNZA J, 2004, MOL HUMAN REPROD, V19
[10]   Human embryonic stem cells: The future is now [J].
Keller, G ;
Snodgrass, HR .
NATURE MEDICINE, 1999, 5 (02) :151-152